Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reinnervate
Sedgefield, England, United Kingdomreprocell.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Reinnervate developed and commercialized the Alvetex family of 3D cell culture products, enabling more physiologically relevant in vitro models for drug discovery screening and academic research. Their technology is used globally by researchers to improve the biological relevance of cell-based assays. The company was acquired by REPROCELL in 2014 to integrate its platform with iPSC-derived cells and expand offerings in drug toxicity testing, neuroscience, and cancer research
- Therapeutic areas
- OncologyNeurologyOther
- Modalities
- Device (3D cell culture scaffold)Platform technology for cell-based assays and tissue models (enabling use with various modalities, e.g., stem cells, small molecules in research)
- Industry
- Non-Drug Biotech
02
Partnerships
REPROCELL group companies post-acquisitionDurham University spinout relationship
Beyond the preview
Go deeper on Reinnervate.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reinnervate.